Skip to main content

Table 1 Characteristics of patients with metastatic neuroblastoma

From: Metastasis pattern and prognosis in children with neuroblastoma

Variable

N (%)

NB with metastasis,

N (%)

NB without

metastasis,

N (%)

P

Total

1224 (100.0)

599 (100.0)

625 (100.0)

 

Age (years)

   

 < 0.001

 ≤ 1

611 (49.9)

257 (42.9)

354 (56.6)

 

 > 1

613 (50.1)

342 (57.1)

271 (43.4)

 

Gender

   

0.024

 Male

632 (51.6)

329 (54.9)

303 (48.5)

 

 Female

592 (48.4)

270 (45.1)

322 (51.5)

 

Race

   

0.338

 White

884 (72.2)

432 (72.1)

452 (72.3)

 

 Black

194 (15.8)

102 (17.0)

92 (14.7)

 

 Others/unknown

146 (11.9)

65 (10.9)

81 (13.0)

 

Primary site

   

 < 0.001

 Adrenal

577 (47.1)

387 (64.6)

190 (30.4)

 

 Soft tissue

304 (24.8)

213 (35.6)

91 (14.6)

 

 Retroperitoneum

124 (10.1)

53 (8.8)

71 (11.4)

 

 Others

219 (17.9)

68 (11.4)

151 (24.2)

 

Tumour grade

   

0.240

 Grades I–II

15 (1.2)

4 (0.7)

11 (1.8)

 

 Grades III–IV

608 (49.7)

316 (52.8)

292 (46.7)

 

 Unknown

611 (49.9)

279 (46.6)

332 (53.1)

 

Laterality

   

 < 0.001

 Unilateral

709 (57.9)

428 (71.5)

281 (45.0)

 

 Bilateral

27 (2.2)

15 (2.5)

12 (1.9)

 

 Unknown

488 (39.9)

156 (26.0)

332 (53.1)

 

Tumour size (cm)

   

 < 0.001

 5

221 (18.1)

75 (12.5)

146 (23.4)

 

 5–10

318 (26.0)

157 (26.2)

161 (25.8)

 

 10

141 (11.5)

88 (14.7)

53 (8.5)

 

 Unknown

544 (44.4)

279 (46.6)

265 (42.4)

 

Histology

   

 < 0.001

 Neuroblastoma-NOS

1003 (81.9)

563 (94.0)

440 (70.4)

 

 Ganglioneuroblastoma

221 (18.1)

36 (6.0)

185 (29.6)

 

Chemotherapy

   

 < 0.001

 Yes

829 (67.7)

565 (94.3)

264 (42.2)

 

 No

395 (32.3)

34 (5.7)

361 (57.8)

 

Surgery

   

0.001

 Yes

939 (76.7)

436 (72.8)

503 (80.5)

 

 No

285 (23.3)

163 (27.2)

122 (19.5)

 

Radiotherapy

   

 < 0.001

 Yes

321 (26.2)

259 (43.2)

62 (9.9)

 

 No

903 (73.8)

340 (56.8)

563 (90.1)

 

SMN

   

 < 0.001

 Yes

25 (2.0)

21 (3.5)

4 (0.6)

 

 No

1199 (98.0)

578 (96.5)

621 (99.4)

 
  1. Abbreviations: SMN second malignant neoplasms, NB neuroblastoma, NOS not otherwise specified, N number